Alendronate May Provide Cardiovascular Benefits; Plus FDA Approves Subcutaneous Tocilizumab

No new safety signals were identified.

Michele B. Kaufman, PharmD, BCGP, is a freelance medical writer based in New York City and a pharmacist at New York Presbyterian Lower Manhattan Hospital.

References

1. Staff. Osteoporosis drug may benefit heart health. FirstWord Pharma. 2018 May 13.
2. Genentech Inc. News release: FDA approves subcutaneous formulation of Actemra for use in active polyarticular juvenile idiopathic arthritis (PJIA), a rare form of juvenile arthritis. 2018 May 14.